NCT00876447 - A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis | Biotech Hunter

Enrollment

397

Participants

Timeline

Start Date

January 1, 2009

Primary Completion Date

June 12, 2013

Study Completion Date

September 4, 2013

Conditions

Overactive Bladder

Interventions

BIOLOGICAL

Botulinum Toxin Type A 300U

Botulinum toxin Type A 300U injections into the detrusor \> 12 weeks as needed for up to 3 years.

BIOLOGICAL

Botulinum Toxin Type A 200U

Botulinum toxin Type A 200U injections into the detrusor \> 12 weeks as needed for up to 3 years.

Trial Locations (22)

Middlebury

Randwick

Innsbruck

Ghent

Rio de Janeiro

Victoria

Ostrava

Salouël

Kiel

Florence

Amsterdam

Epsom

Poznan

Porto

Moscow

Singapore

Prešov

Pretoria

Santa Cruz de Tenerife

Hualien City

Kiev

London